Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call Transcript


Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2025 Earnings Call May 1, 2025 8:00 AM ET

Company Participants

Eric Sciorilli – Head, Investor Relations
Steve Basta – President and Chief Executive Officer
Molly Henderson – Chief Financial and Business Officer
Robert Breedlove – Vice President, Finance and Principal Accounting Officer

Conference Call Participants

Joseph Stringer – Needham & Company
Annabel Samimy – Stifel
Chase Knickerbocker – Craig-Hallum
Yatin Suneja – Guggenheim
Paul Choi – Goldman Sachs
Chengxiang Liu – Evercore

Operator

Hello and welcome to the Phathom Pharmaceuticals’ First Quarter 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s conference is being recorded. With that, I would like to turn the conference over to Eric Sciorilli, Phathom’s Head of Investor Relations. Please go ahead.

Eric Sciorilli

Thank you, operator. Hello, everyone and thank you for joining us this morning to discuss Phathom’s first quarter 2025 results. This morning’s presentation will include remarks from Steve Basta, our President and CEO and Molly Henderson, our Chief Financial and Business Officer. Robert Breedlove, our VP of Finance and Principal Accounting Officer will also be joining the team during the Q&A portion of today’s call.

Just a couple of logistical items before we get started. Earlier this morning, we issued a press release detailing the results we will be discussing during the call. A copy of that press release can be found under the News Releases section of our corporate website. Further, the recording of today’s webcast can be found under the Events and Presentation section of our corporate website.

Before we begin, let me remind you that we will be making a number of forward-looking statements throughout today’s presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Phathom’s control. Actual results can materially differ from the forward-looking statements and any such risks can



#Phathom #Pharmaceuticals #PHAT #Earnings #Call #Transcript

Leave a Reply

Your email address will not be published. Required fields are marked *